In addition to targeting specific enzymes, drugs aim to improve efficacy and reduce adverse reactions by focusing on specific distribution and functions in the pathological stage
It appears that the HOMO-LUMO interaction, through coupling and charge transfer, is the primary factor driving the reactants toward each other
In a study published in JAMA Network Open in January 2025, which included more than 125,000 patients, nearly 65 percent of those taking GLP1s for reasons other than Type 2 diabetes discontinued them within one year
Notably, mutations mainly in pfcrt [59] and pfmdr1 [60] differentially influence quinoline drug action and resistance
Pancreatic enzyme elevations (lipase and amylase) were observed in some orforglipron-treated participants but were mostly asymptomatic and did not correlate with clinical pancreatitis events
How is a granuloma treated